[1]郎凯楠,李 文,李亚平,等.高危型HPV E6/E7 mRNA检测对ASCUS患者分流价值的系统评价[J].郑州大学学报(医学版),2018,(05):604-609.[doi:10.13705/j.issn.1671-6825.2017.12.099]
 LANG Kainan,LI Wen,LI Yaping,et al.Meta analysis for the value of high-risk HPV E6/E7 mRNA test in triage of patients with atypical squamous cells of undetermined significance[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2018,(05):604-609.[doi:10.13705/j.issn.1671-6825.2017.12.099]
点击复制

高危型HPV E6/E7 mRNA检测对ASCUS患者分流价值的系统评价()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2018年05期
页码:
604-609
栏目:
应用研究
出版日期:
2018-09-20

文章信息/Info

Title:
Meta analysis for the value of high-risk HPV E6/E7 mRNA test in triage of patients with atypical squamous cells of undetermined significance
作者:
郎凯楠李 文李亚平刘学友刘玉玲
郑州大学第二附属医院妇产科 郑州 450014
Author(s):
LANG KainanLI WenLI YapingLIU XueyouLIU Yuling
Department of Obstetrics and Gynecology,the Second Affiliated Hospital,Zhengzhou University,Zhengzhou 450014
关键词:
ASCUS 鳞状上皮内高级别病变 HPV DNA HPV E6/E7 mRNA
Keywords:
atypical squamous cell of undetermined significance high-grade squamous intraepithelial lesion HPV DNA HPV E6/E7 mRNA
分类号:
R737.33
DOI:
10.13705/j.issn.1671-6825.2017.12.099
摘要:
目的:系统评价高危型HPV E6/E7 mRNA检测对意义不明确的非典型鳞状细胞(ASCUS)患者分流的诊断价值。方法:通过检索中国生物医学文献数据库、CNKI、万方数据库、PubMed和Web of Science数据库,收集有关HPV E6/E7 mRNA和HPV DNA检测用于ASCUS分流诊断的相关研究,检索时间自建库至2017年12月。由2位研究者根据包容性和排他性标准独立筛选文献、提取数据。结果:共纳入11项研究2 026例患者。Meta分析结果显示,HPV E6/E7 mRNA检测对CINⅡ及以上者的诊断灵敏度(95%CI)为0.84(0.80~0.87),特异度(95%CI)为0.60(0.58~0.63),阳性似然比(95%CI)为2.22(1.76~2.81),阴性似然比(95%CI)为0.30(0.24~0.37),SROC曲线下面积为0.826(Q=0.759)。HPV DNA检测的灵敏度(95%CI)为0.92(0.89~0.95),特异度(95%CI)为0.39(0.37~0.41),阳性似然比(95%CI)为1.54(1.32~1.79),阴性似然比(95%CI)为0.24(0.18~0.33),SROC曲线下面积为0.829(Q=0.761)。结论:HPV E6/E7 mRNA检测对鳞状上皮内高级别病变的诊断优于 HPV DNA,可用于ASCUS患者的分流。
Abstract:
Aim:To systematically evaluate the value of high-risk HPV E6/E7 mRNA testing in triage of patients with atypical squamous cells of undetermined significance(ASCUS).Methods:Studies about diagnostic value of high-risk HPV E6/E7 mRNA test and HPV DNA test in ASCUS patients were retrieved in the databases including Chinese Biomedical Literature,CNKI,Wanfang Database,PubMed and Web of Science databases from construction to December 2017.Two researchers independently screened the literatures according to inclusion and exclusion criteria, extracted data, and assessed the risk of bias.Results:Eleven studies and 2 026 patients were enrolled. The sensitivity(95%CI)of HPV E6/E7 mRNA for high-grade squamous intraepithelial lesion(CINⅡ+)diagnosis was 0.84(0.80-0.87),the specificity(95%CI)was 0.60(0.58-0.63),the positive likelihood ratio(95%CI)was 2.22(1.76-2.81),the negative likelihood ratio(95%CI)was 0.30(0.24-0.37),and the area under the SROC was 0.826(Q=0.759).Those of HPV DNA test was 0.92(0.89-0.95), 0.39(0.37-0.41),1.54(1.32-1.79), 0.24(0.18-0.33),and 0.829(Q =0.761).Conclusion:HPV E6/E7 mRNA test in the diagnosis of high-grade lesions in squamous epithelium is superior to HPV-DNA test,and is helpful for triage of ASCUS.

参考文献/References:

[1] FOLEY G,ALSTON R,GERACI M,et al.Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006[J].Br J Cancer,2011,105(1):177
[2] KURMAN RJ, HENSON DE, HERBST AL, et al. Interim guidelines for management of abnormal cervical cytology:the 1992 National Cancer Institute Workshop[J]. JAMA, 1994, 271(23): 1866
[3] SØRBYE SW, FISMEN S, GUTTEBERG TJ, et al. HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions[J]. PLoS One, 2014, 9(11): e112934
[4] LI Y, RONG S, ZHI Y, et al. Detection of cervical intraepithelial neoplasia with HPVE6/E7 mRNA among women with atypical squamous cells of unknown significance[J]. Int J Gynecol Obstet, 2017, 137(2): 145
[5] THOMSEN LT, DEHLENDORFF C, JUNGE J, et al. Human papillomavirus mRNA and DNA testing in women with atypical squamous cells of undetermined significance: a prospective cohort study[J]. Int J Cancer, 2016, 139(8): 1839
[6] DUVLIS S, POPOVSKA-JANKOVIC K, ARSOVA ZS, et al. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women[J]. J Med Virol, 2015, 87(9): 1578
[7] WHITING PF, RUTJES AW, WESTWOOD ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies[J].Ann Intern Med,2011,155(8):529
[8] 陈海迎, 郑小冬, 郭敏,等. 高危型人乳头瘤病毒E6/E7检测在宫颈细胞学ASC-US分流管理中的应用[J].中国妇幼保健, 2015, 30(35): 6186
[9] 吕涛, 吴忧, 廖秦平,等. 高危型人乳头瘤病毒E6/E7 mRNA在宫颈细胞学ASCUS/LSIL/ASC-H分流中的意义[J]. 现代妇产科进展, 2017, 26(9):670
[10]张月辉, 潘嫱微, 张红萍, 等. 高危型HPV E6/E7 mRNA检测在ASC-US分流中的诊断价值[J]. 医学研究杂志, 2016, 45(11): 157
[11]潘琼慧, 黄凌霄, 朱雪燕, 等. HR-HPV E6/E7 mRNA在宫颈细胞学ASCUS分流诊断中的意义[J]. 浙江医学, 2016, 38(13): 1089
[12]朱远航, 任琛琛, 张小安, 等. HPV E6/E7 mRNA检测对ASCUS患者临床分层处理价值评价[J]. 实用妇产科杂志, 2017, 33(8): 595
[13]潘嫱微, 陈育梅, 潘嘉佳, 等. HPV E6/E7 mRNA检测用于ASCUS患者诊断分流的临床研究[J]. 中国计划生育学杂志, 2015, 23(7): 471
[14]黄凌霄, 潘琼慧, 郑建琼, 等. HPV E6/E7 mRNA在CINII及以上病变中的诊断价值[J]. 温州医科大学学报, 2015, 45(8): 583
[15]REN C, ZHU Y, YANG L, et al. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS papanicolaou smears[J].Arch Gynecol Obstet, 2018,297(2):425
[16]ALAGHEHBANDAN R, FONTAINE D,BENTLEY J,et al. Performance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology[J]. Diagn Cytopathol, 2013, 41(9):767
[17]WALDSTROM M, ORNSKOV D.Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance(ASC-US)[J].Cytopathology,2012,23(6):389
[18]VINOKUROVA S,WENTZENSEN N,Kraus I,et al.Type-dependent integration frequency of human papillomavirus genomes in cervical lesions[J].Cancer Res,2008,68(1): 307
[19]BRANISLAV RN,ANA MARIA JJ,LUKAS N, et al.Relevance of infection with human papillomavirus:the role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins(Review)[J].Int J Oncol,2013,43(6):1754
[20]PIERRY D,WEISS G,LACK B,et al.Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN2+ in cervical biopsies better than Papanicolaou screening for women regardless of age[J].Arch Pathol Lab Med,2012,136(8):956

备注/Memo

备注/Memo:
【基金项目】河南省科技攻关计划(172102310031)
【作者简介】刘玉玲,通信作者,女,1964年5月生,本科,教授,主任医师,研究方向:妇科肿瘤,E-mail:ZZly163@163.com
更新日期/Last Update: 2018-09-20